Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis Moscarello MA; Mastronardi FG; Wood DDNeurochem Res 2007[Feb]; 32 (2): 251-6The pathogenesis of MS is unknown. In our studies, we have demonstrated an important role for citrullinated myelin basic protein (MBP). The accompanying loss of positive charge compromises the ability of MBP to interact with the lipid bilayer. The conversion of arginine to citrulline in brain is carried out by an enzyme peptidyl arginine deiminase (PAD) 2. The amount of PAD 2 in brain was increased in MS normal-appearing white matter. The mechanism responsible for this increase involved hypomethylation of the promoter region in the PAD 2 gene in MS, but no change (compared to normal) was found in thymus tissue DNA from the same MS patients. In addition, no change was observed in other neurological diseases, including Alzheimer's, Parkinson's, and Huntington's. We propose that citrullinated MBP, resulting from elevated levels of PAD 2 represents an important biochemical pathway in the pathogenesis of MS.|Apoptosis[MESH]|Citrulline/*physiology[MESH]|Humans[MESH]|Hydrolases/metabolism[MESH]|Methylation[MESH]|Multiple Sclerosis/enzymology/*etiology[MESH]|Myelin Basic Protein/*metabolism[MESH]|Oligodendroglia/physiology[MESH]|Protein Conformation/drug effects[MESH]|Protein Processing, Post-Translational[MESH]|Protein-Arginine Deiminases[MESH] |